BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weiss KH, Runz H, Noe B, Gotthardt DN, Merle U, Ferenci P, Stremmel W, Füllekrug J. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J Inherit Metab Dis 2010;33 Suppl 3:S233-40. [PMID: 20517649 DOI: 10.1007/s10545-010-9123-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Arruda WO, Munhoz RP, de Bem RS, Deguti MM, Barbosa ER, Zavala JA, Teive HA. Pathogenic compound heterozygous ATP7B mutations with hypoceruloplasminaemia without clinical features of Wilson’s disease. Journal of Clinical Neuroscience 2014;21:335-6. [DOI: 10.1016/j.jocn.2013.02.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
2 Medici V, Shibata NM, Kharbanda KK, LaSalle JM, Woods R, Liu S, Engelberg JA, Devaraj S, Török NJ, Jiang JX, Havel PJ, Lönnerdal B, Kim K, Halsted CH. Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease. Hepatology 2013;57:555-65. [PMID: 22945834 DOI: 10.1002/hep.26047] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
3 Overeem AW, Klappe K, Parisi S, Klöters-Planchy P, Mataković L, du Teil Espina M, Drouin CA, Weiss KH, van IJzendoorn SCD. Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity. J Hepatol 2019;71:344-56. [PMID: 30965071 DOI: 10.1016/j.jhep.2019.03.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
4 Glavind E, Gotthardt DN, Pfeiffenberger J, Sandahl TD, Bashlekova T, Willemoe GL, Hasselby JP, Weiss KH, Møller HJ, Vilstrup H, Lee WM, Schilsky ML, Ott P, Grønbæk H. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. Orphanet J Rare Dis 2020;15:173. [PMID: 32615997 DOI: 10.1186/s13023-020-01452-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bruha R, Vitek L, Marecek Z, Pospisilova L, Nevsimalova S, Martasek P, Petrtyl J, Urbanek P, Jiraskova A, Malikova I, Haluzik M, Ferenci P. Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J Inherit Metab Dis 2012;35:541-8. [PMID: 22139496 DOI: 10.1007/s10545-011-9422-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
6 Li X, Montgomery SB. Detection and impact of rare regulatory variants in human disease. Front Genet 2013;4:67. [PMID: 23755067 DOI: 10.3389/fgene.2013.00067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
7 Chen Y, Wang Z, Luo Z, Zhao N, Yang S, Tang Y. Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis. Ital J Pediatr 2016;42:50. [PMID: 27209435 DOI: 10.1186/s13052-016-0262-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
8 Seo GH, Kim Y, Oh SH, Chung SJ, Choi IH, Kim G, Yum M, Choi J, Kim KM, Ko T, Lee BH, Yoo H. Biochemical and molecular characterisation of neurological Wilson disease. J Med Genet 2018;55:587-93. [DOI: 10.1136/jmedgenet-2017-105214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Montes S, Rivera-Mancia S, Diaz-Ruiz A, Tristan-Lopez L, Rios C. Copper and copper proteins in Parkinson's disease. Oxid Med Cell Longev 2014;2014:147251. [PMID: 24672633 DOI: 10.1155/2014/147251] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 10.5] [Reference Citation Analysis]
10 Corbee RJ, Penning LC. COMMD1 Exemplifies the Power of Inbred Dogs to Dissect Genetic Causes of Rare Copper-Related Disorders. Animals (Basel) 2021;11:601. [PMID: 33668783 DOI: 10.3390/ani11030601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kodama H, Fujisawa C, Bhadhprasit W. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment. Curr Drug Metab. 2012;13:237-250. [PMID: 21838703 DOI: 10.2174/138920012799320455] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
12 Kores K, Lešnik S, Bren U, Janežič D, Konc J. Discovery of Novel Potential Human Targets of Resveratrol by Inverse Molecular Docking. J Chem Inf Model 2019;59:2467-78. [PMID: 30883115 DOI: 10.1021/acs.jcim.8b00981] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
13 Chang IJ, Hahn SH. The genetics of Wilson disease. 1st ed. Elsevier. 2017;. [PMID: 28433102 DOI: 10.1016/b978-0-444-63625-6.00003-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 11.8] [Reference Citation Analysis]
14 Wu X, Leegwater PA, Fieten H. Canine Models for Copper Homeostasis Disorders. Int J Mol Sci 2016;17:196. [PMID: 26861285 DOI: 10.3390/ijms17020196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
15 LaCasse EC. Pulling the plug on a cancer cell by eliminating XIAP with AEG35156. Cancer Lett 2013;332:215-24. [PMID: 22776562 DOI: 10.1016/j.canlet.2012.06.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
16 Kieffer DA, Medici V. Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence. Liver Res 2017;1:121-30. [PMID: 29270329 DOI: 10.1016/j.livres.2017.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, Pende D, Griffiths G, Aricò M. Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning. Front Immunol 2014;5:167. [PMID: 24795715 DOI: 10.3389/fimmu.2014.00167] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
18 Weiss KH, Stremmel W. Evolving Perspectives in Wilson Disease: Diagnosis, Treatment and Monitoring. Curr Gastroenterol Rep 2012;14:1-7. [DOI: 10.1007/s11894-011-0227-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
19 Khan HN, Wasim M, Ayesha H, Awan FR. Molecular genetic diagnosis of Wilson disease by ARMS-PCR in a Pakistani family. Mol Biol Rep 2018;45:2585-91. [DOI: 10.1007/s11033-018-4426-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Marivin A, Berthelet J, Plenchette S, Dubrez L. The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress. Cells 2012;1:711-37. [PMID: 24710527 DOI: 10.3390/cells1040711] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
21 Medici V, Weiss K. Genetic and environmental modifiers of Wilson disease. Wilson Disease. Elsevier; 2017. pp. 35-41. [DOI: 10.1016/b978-0-444-63625-6.00004-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
22 Roscioli E, Hamon R, Ruffin RE, Zalewski P, Grant J, Lester S. X-linked inhibitor of apoptosis single nucleotide polymorphisms and copy number variation are not risk factors for asthma. Respirology 2013;18:697-703. [PMID: 23418891 DOI: 10.1111/resp.12065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Li Y, Fan H, Yuan F, Lu L, Liu J, Feng W, Zhang HG, Chen SY. Sulforaphane Protects Against Ethanol-Induced Apoptosis in Human Neural Crest Cells Through Diminishing Ethanol-Induced Hypermethylation at the Promoters of the Genes Encoding the Inhibitor of Apoptosis Proteins. Front Cell Dev Biol 2021;9:622152. [PMID: 33634123 DOI: 10.3389/fcell.2021.622152] [Reference Citation Analysis]
24 Sánchez-Monteagudo A, Ripollés E, Berenguer M, Espinós C. Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines 2021;9:1100. [PMID: 34572285 DOI: 10.3390/biomedicines9091100] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Krawczyk M, Müllenbach R, Weber SN, Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol. 2010;7:669-681. [PMID: 21045792 DOI: 10.1038/nrgastro.2010.170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
26 Litwin T, Gromadzka G, Samochowiec J, Grzywacz A, Członkowski A, Członkowska A. Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease. JIMD Rep 2013;8:73-80. [PMID: 23430523 DOI: 10.1007/8904_2012_163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
27 Muchenditsi A, Talbot CC Jr, Gottlieb A, Yang H, Kang B, Boronina T, Cole R, Wang L, Dev S, Hamilton JP, Lutsenko S. Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease. Sci Rep 2021;11:5659. [PMID: 33707579 DOI: 10.1038/s41598-021-84894-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Przybyłkowski A, Gromadzka G, Członkowska A. Polymorphisms of metal transporter genes DMT1 and ATP7A in Wilson's disease. J Trace Elem Med Biol 2014;28:8-12. [PMID: 24120082 DOI: 10.1016/j.jtemb.2013.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
29 Berthelet J, Dubrez L. Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs). Cells 2013;2:163-87. [PMID: 24709650 DOI: 10.3390/cells2010163] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 9.4] [Reference Citation Analysis]
30 Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11:1028-35.e1-2. [PMID: 23542331 DOI: 10.1016/j.cgh.2013.03.012] [Cited by in Crossref: 108] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
31 Wu X, den Boer ER, Vos-Loohuis M, Steenbeek FGV, Monroe GR, Nijman IJ, Leegwater PAJ, Fieten H. Investigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers. Life (Basel) 2020;10:E266. [PMID: 33142854 DOI: 10.3390/life10110266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, Ferenci P, Stremmel W. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011; 140: 1189-1198. e1. [PMID: 21185835 DOI: 10.1053/j.gastro.2010.12.034] [Cited by in Crossref: 120] [Cited by in F6Publishing: 91] [Article Influence: 10.0] [Reference Citation Analysis]
33 Weiss KH, Schäfer M, Gotthardt DN, Angerer A, Mogler C, Schirmacher P, Schemmer P, Stremmel W, Sauer P. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease. Clin Transplant. 2013;27:914-922. [PMID: 24118554 DOI: 10.1111/ctr.12259] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
34 Hien NK, Bay MV, Bao NC, Vo QV, Cuong ND, Thien TV, Nhung NTA, Van DU, Nam PC, Quang DT. Coumarin-Based Dual Chemosensor for Colorimetric and Fluorescent Detection of Cu2+ in Water Media. ACS Omega 2020;5:21241-9. [PMID: 32875260 DOI: 10.1021/acsomega.0c03097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Medici V, LaSalle JM. Genetics and epigenetic factors of Wilson disease. Ann Transl Med 2019;7:S58. [PMID: 31179295 DOI: 10.21037/atm.2019.01.67] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]